Targeting of NSCLC in 2011 by Alice Shaw, MD, PhD
6 Visualizzazioni
• 07/30/23
0
0
Incorporare
administrator
Iscritti
Dr. Shaw describes the current data supporting the use of EGFR and ALK targeted therapies in treating molecularly genotyped patients with advanced NSCLC at the 2011 Chabner Colloquium.
Mostra di più
Commenti su Facebook
SORT BY-
I migliori commenti
-
Ultimi commenti